Liu Ziyu, Guan Zhiyuan, Lan Hongyu, Zhao Yan, Ye Zhiming, Lv Daojun, Yu Qingfeng, Wang Ming, Peng Kaoqing, Fu Nanfei, Mazzon Giorgio, Gu Di
Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Nanshan College, Guangzhou Medical University, Guangzhou, China.
Front Surg. 2022 Apr 28;9:848923. doi: 10.3389/fsurg.2022.848923. eCollection 2022.
The Visual Prostate Symptom Score (VPSS) is used for the assessment of lower urinary tract symptoms (LUTS). It is usually administered by general practitioners (GPs), but in these cases, outcomes do not seem to be reflecting the real conditions of a patient well, with consequent risks of misestimations and misinterpretations. We developed an electronic audiovisual version of VPSS (EPSS), a new symptom scale based on a telemedicine mobile light-based app. The aim of this study is to test and evaluate its reliability.
We enrolled male patients aged between 50 and 80 years across 24 community-based healthcare facilities in Guangzhou, China. Patients were asked to complete the Chinese version of VPSS and EPSS before consultation with the urology specialists. Patients were divided into two groups based on age. First, we analyzed the rate of full understanding of EPSS using a chi-square test. Then, we analyzed the difference between each score of EPSS, VPSS, and outcomes measured by specialists, used as the reference score (RS). Finally, the outcomes were analyzed with the Spearman test and Bartlett test separately.
Seventy-nine male patients were included (mean age 70.42 years). Patients were divided into two groups: group 1 (>70 years, = 40) and group 2 (<70 years, = 39). The full-understanding rates in groups 1 and 2 were 50% and 64.1%, respectively. No significant differences were noted between groups ( = 0.206). A -test was presented between each question of VPSS, EPSS, and RS. All questions did not display significant differences ( > 0.05); total scores from the three scales had no significant differences in the evaluation of LUTS. We further explored the variations of choices made by patients in different scales. Spearman's test among VPSS, EPSS, and RS showed positive correlations, and coefficients of the total score were 0.92, 0.91, and 0.93 ( < 0.05).
EPSS can be easily used in a significant number of patients and showed correlation with the VPSS and RS. Moreover, certain items resulted in better performance than VPSS. The results showed that EPSS could be a valuable option for both patients and GPs monitoring LUTS and particularly helpful when teleconsultations are considered, especially during the COVID-19 pandemic.
视觉前列腺症状评分(VPSS)用于评估下尿路症状(LUTS)。它通常由全科医生(GPs)进行评估,但在这些情况下,结果似乎不能很好地反映患者的实际情况,从而存在估计错误和解释错误的风险。我们开发了一种电子视听版的VPSS(EPSS),这是一种基于远程医疗移动光应用程序的新症状量表。本研究的目的是测试和评估其可靠性。
我们在中国广州的24个社区医疗机构招募了年龄在50至80岁之间的男性患者。患者在咨询泌尿外科专家之前被要求完成中文版的VPSS和EPSS。患者根据年龄分为两组。首先,我们使用卡方检验分析对EPSS的完全理解率。然后,我们分析了EPSS、VPSS的每个分数与作为参考分数(RS)的专家测量结果之间的差异。最后,分别用Spearman检验和Bartlett检验分析结果。
纳入79名男性患者(平均年龄70.42岁)。患者分为两组:第1组(>70岁,n = 40)和第2组(<70岁,n = 39)。第1组和第2组的完全理解率分别为50%和64.1%。两组之间未观察到显著差异(P = 0.206)。对VPSS、EPSS和RS的每个问题进行了t检验。所有问题均未显示出显著差异(P>0.05);三种量表的总分在评估LUTS方面没有显著差异。我们进一步探讨了患者在不同量表中做出的选择的差异。VPSS、EPSS和RS之间的Spearman检验显示出正相关,总分的系数分别为0.92、0.91和0.93(P<0.05)。
EPSS可以很容易地应用于大量患者,并与VPSS和RS显示出相关性。此外,某些项目的表现优于VPSS。结果表明,EPSS对于监测LUTS的患者和全科医生来说可能是一个有价值的选择,特别是在考虑远程会诊时,尤其是在COVID-19大流行期间特别有帮助。